Comparative effectiveness of nab-paclitaxel vs. paclitaxel monotherapy as first-line (1L) treatment of metastatic triple-negative breast cancer (mTNBC) in US clinical practice

T. Luhn, S. Chui, A. Hsieh, J. Yi, A. Mecke, P. Bajaj, W. Hasnain, A. Falgas, T. G.N. Ton, A. Kurian

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish (US)
    Pages (from-to)viii101
    JournalAnnals of oncology : official journal of the European Society for Medical Oncology
    StatePublished - Oct 1 2018

    ASJC Scopus subject areas

    • Hematology
    • Oncology

    Cite this